A Maisel

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings
    Emily Lubien
    Division of Cardiology, Department of Medicine, Veteran's Affairs Medical Center, and University of California, San Diego, USA
    Circulation 105:595-601. 2002
  2. ncbi Short-term serial sampling of natriuretic peptides in patients presenting with chest pain
    Gene Kwan
    Division of Cardiology, Department of Medicine, Veterans Affairs Healthcare System San Diego and University of California, San Diego, California 92161, USA
    J Am Coll Cardiol 49:1186-92. 2007
  3. ncbi Natriuretic peptides in acute coronary syndromes: prognostic value and clinical implications
    Dimitrios Farmakis
    Second Department of Cardiology, Athens University Medical School, Attikon University Hospital, Athens, Greece
    Congest Heart Fail 14:25-9. 2008
  4. ncbi In-hospital percentage BNP reduction is highly predictive for adverse events in patients admitted for acute heart failure: the Italian RED Study
    Salvatore Di Somma
    Emergency Medicine Department, II Medical School University La Sapienza, Sant Andrea Hospital, Via di Grottarossa, 1039 Roma 00189, Italy
    Crit Care 14:R116. 2010
  5. ncbi Experimental autoimmune myocarditis produced by adoptive transfer of splenocytes after myocardial infarction
    A Maisel
    Department of Medicine, Veterans Affairs Medical Center and University of California, San Diego 921161, USA
    Circ Res 82:458-63. 1998
  6. ncbi Nesiritide: a new therapy for the treatment of heart failure
    Alan S Maisel
    San Diego VA Healthcare System, CA 92161, USA
    Cardiovasc Toxicol 3:37-42. 2003
  7. ncbi Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study
    Alan S Maisel
    Cardiology 111 A, San Diego VA Medical Center, 3350 La Jolla Village Drive, San Diego, CA 92161, USA
    J Am Coll Cardiol 41:2010-7. 2003
  8. ncbi State of the art: using natriuretic peptide levels in clinical practice
    Alan Maisel
    VA San Diego Healthcare System Cardiology, San Diego, CA 92161, USA
    Eur J Heart Fail 10:824-39. 2008
  9. ncbi The diagnosis of acute congestive heart failure: role of BNP measurements
    Alan S Maisel
    Division of Cardiology and Department of Medicine, San Diego VA Healthcare System, CA 921161, USA
    Heart Fail Rev 8:327-34. 2003
  10. ncbi Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis
    Alan S Maisel
    Veterans Administration, San Diego, California 92161, USA
    J Am Coll Cardiol 52:534-40. 2008

Detail Information

Publications75

  1. ncbi Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings
    Emily Lubien
    Division of Cardiology, Department of Medicine, Veteran's Affairs Medical Center, and University of California, San Diego, USA
    Circulation 105:595-601. 2002
    ..In patients with normal systolic function, elevated BNP levels and diastolic filling abnormalities might help to reinforce the diagnosis diastolic dysfunction...
  2. ncbi Short-term serial sampling of natriuretic peptides in patients presenting with chest pain
    Gene Kwan
    Division of Cardiology, Department of Medicine, Veterans Affairs Healthcare System San Diego and University of California, San Diego, California 92161, USA
    J Am Coll Cardiol 49:1186-92. 2007
    ..The purpose of this study was to characterize the diagnostic and prognostic utility of short-term dynamic changes in natriuretic peptides in patients presenting with chest pain...
  3. ncbi Natriuretic peptides in acute coronary syndromes: prognostic value and clinical implications
    Dimitrios Farmakis
    Second Department of Cardiology, Athens University Medical School, Attikon University Hospital, Athens, Greece
    Congest Heart Fail 14:25-9. 2008
    ..In conclusion, natriuretic peptide values may improve risk stratification in ACS when used in addition to troponin levels and other prognostic markers, but more data are needed to define their role in ACS therapy...
  4. ncbi In-hospital percentage BNP reduction is highly predictive for adverse events in patients admitted for acute heart failure: the Italian RED Study
    Salvatore Di Somma
    Emergency Medicine Department, II Medical School University La Sapienza, Sant Andrea Hospital, Via di Grottarossa, 1039 Roma 00189, Italy
    Crit Care 14:R116. 2010
    ....
  5. ncbi Experimental autoimmune myocarditis produced by adoptive transfer of splenocytes after myocardial infarction
    A Maisel
    Department of Medicine, Veterans Affairs Medical Center and University of California, San Diego 921161, USA
    Circ Res 82:458-63. 1998
    ..Additionally, this might be a useful model in which to study other immune-mediated cardiomyopathies...
  6. ncbi Nesiritide: a new therapy for the treatment of heart failure
    Alan S Maisel
    San Diego VA Healthcare System, CA 92161, USA
    Cardiovasc Toxicol 3:37-42. 2003
    ..As a result, nesiritide is not arrhythmogenic. Nesiritide should be considered for patients presenting with acutely typical or useful decompensated heart failure, especially those with dyspnea at rest or with minimal activity...
  7. ncbi Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study
    Alan S Maisel
    Cardiology 111 A, San Diego VA Medical Center, 3350 La Jolla Village Drive, San Diego, CA 92161, USA
    J Am Coll Cardiol 41:2010-7. 2003
    ..This study examines B-type natriuretic peptide (BNP) levels in patients with systolic versus non-systolic dysfunction presenting with shortness of breath...
  8. ncbi State of the art: using natriuretic peptide levels in clinical practice
    Alan Maisel
    VA San Diego Healthcare System Cardiology, San Diego, CA 92161, USA
    Eur J Heart Fail 10:824-39. 2008
    ..9) NP levels can accelerate accurate diagnosis of heart failure presenting in primary care. 10) NP levels may be helpful to screen for asymptomatic left ventricular dysfunction in high-risk patients...
  9. ncbi The diagnosis of acute congestive heart failure: role of BNP measurements
    Alan S Maisel
    Division of Cardiology and Department of Medicine, San Diego VA Healthcare System, CA 921161, USA
    Heart Fail Rev 8:327-34. 2003
    ..Finally, it is possible that use of BNP levels might not only be helpful in assessing whether or not a dyspneic patient has heart failure, but it my turn out to be useful in making both triage and management decisions...
  10. ncbi Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis
    Alan S Maisel
    Veterans Administration, San Diego, California 92161, USA
    J Am Coll Cardiol 52:534-40. 2008
    ....
  11. ncbi B-type natriuretic peptide: the level and the drug--partners in the diagnosis of congestive heart failure
    Vikas Bhalla
    Division of Cardiology and General Internal Medicine, and the Department of Medicine and Nursing, Veterans Affairs Medical Center, and the University of California, San Diego, CA 92161, USA
    Congest Heart Fail 10:3-27. 2004
    ..This article reviews the literature concerning the use of these peptides in a variety of clinical scenarios and the use of recombinant B-type natriuretic peptide in decompensated heart failure...
  12. ncbi Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial
    Alan Maisel
    VA San Diego Healthcare System, 3350 La Jolla Village Drive, San Diego, CA 92161, USA
    J Am Coll Cardiol 58:1057-67. 2011
    ..The aim of this study was to determine the prognostic utility of midregion proadrenomedullin (MR-proADM) in all patients, cardiac and noncardiac, presenting with acute shortness of breath...
  13. ncbi Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the Breathing Not Properly (BNP) multinational study
    Alan S Maisel
    University of California, San Diego, Veteran s Affairs Medical Center, San Diego, Calif 92161, USA
    Am Heart J 147:1078-84. 2004
    ..B-type natriuretic peptide (BNP) is secreted from the cardiac ventricles in response to increased wall tension...
  14. ncbi Cardiac biomarkers: a contemporary status report
    Alan S Maisel
    Department of Medicine, Veterans Affairs San Diego Healthcare System and University of California, San Diego, CA 92161, USA
    Nat Clin Pract Cardiovasc Med 3:24-34. 2006
    ..At the end of this review we highlight some of the biomarker-guided approaches and strategies that might lead to better and more-effective care of patients...
  15. ncbi Cardiovascular and renal surrogate markers in the clinical management of hypertension
    Alan S Maisel
    Veterans Affairs San Diego Healthcare System, San Diego, CA 92161, USA
    Cardiovasc Drugs Ther 23:317-26. 2009
    ..Surrogate markers are increasingly employed as predictive endpoints for treatment...
  16. ncbi Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial
    Alan Maisel
    VA San Diego Healthcare System, San Diego, California 92161, USA
    J Am Coll Cardiol 55:2062-76. 2010
    ....
  17. ncbi Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction
    A S Maisel
    Division of Cardiology, Veterans Affairs Medical Center and University of California, 3350 La Jolla Village Dr, San Diego, CA 92161, USA
    Am Heart J 141:367-74. 2001
    ..We hypothesized that BNP might therefore be useful as a screening tool before echocardiography in patients with suspected LV dysfunction...
  18. ncbi Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath
    Alan Maisel
    University of California San Diego, Veterans Affairs Medical Center, San Diego, California 92161, USA
    J Am Coll Cardiol 44:1328-33. 2004
    ....
  19. ncbi Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: the NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial
    Alan S Maisel
    San Diego Veterans Affairs Medical Center, 3350 La Jolla Village Drive, University California, San Diego, CA, USA
    Eur J Heart Fail 13:846-51. 2011
    ..Renal dysfunction portends significant risk after discharge from acute heart failure (AHF). Thus, a sensitive marker of renal injury might also help to risk stratify HF patients...
  20. ncbi B-type natriuretic peptide in the diagnosis and management of congestive heart failure
    A Maisel
    Coronary Care Unit, Heart Failure Research Unit, Division of Cardiology, Department of Medicine, VA San Diego Health Care System, University of California, San Diego, California, USA
    Cardiol Clin 19:557-71. 2001
    ..Finally, the role of BNP in the outpatient cardiac or primary care clinic may be one of critical importance in titration of therapies and in assessment of the state of neurohormonal compensation of the patient...
  21. ncbi B-type natriuretic peptide levels: diagnostic and therapeutic potential
    A Maisel
    Division of Cardiology and Department of Medicine, San Diego VA Healthcare System and University of California, San Diego, CA 92116, USA
    Cardiovasc Toxicol 1:159-64. 2001
    ..Measurement of BNP may also be an excellent screening tool for LV dysfunction. Key Words: Natriuretic peptides; neurohormonal; left-ventricular pressure;..
  22. ncbi Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure
    Alan S Maisel
    University of California, San Diego, Veterans Affairs Medical Center, San Diego 92161, USA
    N Engl J Med 347:161-7. 2002
    ..B-type natriuretic peptide is released from the cardiac ventricles in response to increased wall tension...
  23. ncbi Use of BNP levels in monitoring hospitalized heart failure patients with heart failure
    Alan S Maisel
    Division of Cardiology, Department of Medicine, San Diego VA Healthcare System, San Diego, CA 92161, USA
    Heart Fail Rev 8:339-44. 2003
  24. ncbi A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study
    R Kazanegra
    Division of Cardiology, Department of Medicine, Veteran's Affairs Medical Center, San Diego, California 92161, USA
    J Card Fail 7:21-9. 2001
    ..Although BNP levels will not obviate the need for invasive hemodynamic monitoring, it may be a useful adjunct in tailoring therapy to these patients...
  25. ncbi B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea
    Alex Harrison
    Division of Cardiology and General Internal Medicine, Department of Medicine, Veterans Affairs Medical Center and University of California, San Diego, CA, USA
    Ann Emerg Med 39:131-8. 2002
    ..CONCLUSION: In this study population, BNP levels measured in patients presenting with dyspnea to the ED are highly predictive of cardiac events over the next 6 months...
  26. ncbi Correlation and prognostic utility of B-type natriuretic peptide and its amino-terminal fragment in patients with chronic kidney disease
    Wendy J Austin
    Division of Cardiology and the Department of Medicine, Veteran Affairs Healthcare System San Diego and University of California, San Diego, USA
    Am J Clin Pathol 126:506-12. 2006
    ..99). Both peptides are useful prognostic tools for predicting mortality and cardiac hospitalization in renal patients...
  27. ncbi Serial sampling of ST2 predicts 90-day mortality following destabilized heart failure
    Saskia Boisot
    University of California at San Diego, Veteran Affairs San Diego Healthcare System, San Diego, CA 92161, USA
    J Card Fail 14:732-8. 2008
    ..To prospectively determine the prognostic utility of serial sampling of the interleukin-1 receptor family member, ST2, for predicting 90-day mortality in patients with heart failure (HF) admitted to a Veteran Affairs Medical Center...
  28. ncbi How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly Multinational Study
    Lori B Daniels
    University of California, San Diego, CA, USA
    Am Heart J 151:999-1005. 2006
    ..A lower cut-point (BNP > or = 54 pg/mL) should be used in severely obese patients to preserve sensitivity. A higher cut-point in lean patients (BNP > or = 170 pg/mL) could be used to increase specificity...
  29. ncbi Pro-B-type natriuretic peptide levels in acute decompensated heart failure
    Stephen W Waldo
    University of California at San Diego, Veterans Affairs San Diego Healthcare System, San Diego, California 92161, USA
    J Am Coll Cardiol 51:1874-82. 2008
    ..The present study sought to evaluate the clinical utility of pro-B-type natriuretic peptides (proBNP) in patients admitted with acute decompensated heart failure...
  30. ncbi Predictors of elevated B-type natriuretic peptide concentrations in dyspneic patients without heart failure: an analysis from the breathing not properly multinational study
    Cathrine W Knudsen
    University of California, San Diego, Veteran's Affairs Medical Center, San Diego, CA, USA
    Ann Emerg Med 45:573-80. 2005
    ..CONCLUSION: Knowledge of these commonly obtained variables should aid clinicians in the interpretation of moderately elevated BNP results in patients presenting with acute dyspnea in the emergency department...
  31. ncbi Diagnostic ability of B-type natriuretic peptide and impedance cardiography: testing to identify left ventricular dysfunction in hypertensive patients
    Vikas Bhalla
    Division of Cardiology and the Department of Medicine, Veterans Affairs Medical Center and University of California, San Diego, San Diego, California 92161, USA
    Am J Hypertens 18:73S-81S. 2005
    ..73). CONCLUSIONS: In this high-risk hypertensive population, BNP, NT-BNP, and ICG were useful to identify the presence of LVD. The use of ICG with natriuretic peptide testing may improve the ability to detect LVD...
  32. ncbi A prospective study in search of an optimal B-natriuretic peptide level to screen patients for cardiac dysfunction
    Dunya Atisha
    Division of Cardiology and the Department of Medicine, Veteran's Affairs Medical Center and University of California, San Diego, Calif 92161, USA
    Am Heart J 148:518-23. 2004
    ....
  33. ncbi B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study
    Peter A McCullough
    University of California, San Diego Veteran s Affairs Medical Center, San Diego, CA, USA
    Am J Kidney Dis 41:571-9. 2003
    ..However, relationships between BNP, renal function, and heart failure as an emergency diagnosis are unknown...
  34. ncbi Natriuretic peptides as diagnostic test: lessons from the first 5 years of clinical application
    Lori B Daniels
    University of California San Diego, San Diego, CA, USA
    Heart Fail Clin 2:299-309. 2006
  35. ncbi Critical pathway for the management of acute heart failure at the Veterans Affairs San Diego Healthcare System: transforming performance measures into cardiac care
    Nancy J Gardetto
    San Diego VA Medical Center, University of California, San Diego, CA, USA
    Crit Pathw Cardiol 7:153-72. 2008
    ..Consequently, the development of clinical pathways has the potential to reduce the current variability in care, enhance guideline adherence, and improve outcomes for patients...
  36. ncbi Cardiac natriuretic peptides:a proteomic window to cardiac function and clinical management
    Alan S Maisel
    Department of Medicine, Division of Cardiology, San Diego VA Healthcare System and University of California, San Diego, San Diego, California, USA
    Rev Cardiovasc Med 4:S3-12. 2003
    ..Thus, it is likely that future algorithms incorporating BNP levels and other clinical indicators will become available to guide critical-care physicians in making management decisions for their CHF patients...
  37. ncbi Natriuretic peptides
    Lori B Daniels
    Division of Cardiology, University of California at San Diego, and Veteran s Affairs San Diego Healthcare System, San Diego, California 92037 1300, USA
    J Am Coll Cardiol 50:2357-68. 2007
    ..Knowing a patient's NP levels might thus assist with hemodynamic assessment and subsequent treatment titration. Monitoring NP levels in the outpatient setting might also improve patient care and outcomes...
  38. ncbi Usefulness of B-type natriuretic peptide levels in predicting hemodynamic and clinical decompensation
    Pam R Taub
    University of California San Diego Medical Center, San Diego, CA 92103 8411, USA
    Heart Fail Clin 5:169-75. 2009
    ..Tools such as the natriuretic peptides are important adjuncts to the physical examination and chest radiographs and often obviate the need for invasive hemodynamic assessment...
  39. ncbi Highlights of the year in JACC 2007
    Anthony N Demaria
    Cardiology Division, University of California-San Diego, San Diego, California 92103-8411, USA
    J Am Coll Cardiol 51:490-512. 2008
  40. ncbi Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study
    Lori B Daniels
    Division of Cardiology, Department of Medicine, University of California at San Diego, San Diego, California, USA
    J Am Coll Cardiol 52:450-9. 2008
    ..This study investigated the prognostic value of detectable cardiac troponin T (TnT) and elevated N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels in a population of community-dwelling older adults...
  41. ncbi Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery
    Ryan Hutfless
    University of California, San Diego, San Diego, California, USA
    J Am Coll Cardiol 43:1873-9. 2004
    ..Postoperatively, elevated peak BNP levels and elevated change to peak BNP levels were associated with prolonged hospital stay and mortality within one year...
  42. ncbi Physical fitness attenuates leukocyte-endothelial adhesion in response to acute exercise
    Paul J Mills
    Department of Psychiatry, University of California, San Diego, La Jolla, CA, USA
    J Appl Physiol 101:785-8. 2006
    ..The findings provide evidence of how physical fitness might protect individuals from inflammatory responses to exercise...
  43. ncbi Prognosis of stage A or B heart failure patients with elevated B-type natriuretic peptide levels
    Lori B Daniels
    Division of Cardiology, Department of Medicine, University of California at San Diego, San Diego, CA, USA
    J Card Fail 16:93-8. 2010
    ....
  44. ncbi B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study
    Peter A McCullough
    University of California, Veteran s Affairs Medical Center, San Diego, USA
    Circulation 106:416-22. 2002
    ..We sought to determine the degree to which B-type natriuretic peptide (BNP) adds to clinical judgment in the diagnosis of congestive heart failure (CHF)...
  45. ncbi Relationship of B-type natriuretic peptide and anemia in patients with and without heart failure: a substudy from the Breathing Not Properly (BNP) Multinational Study
    Alan H B Wu
    Department of Laboratory Medicine, University of California, San Francisco, San Francisco General Hospital, 1001 Potrero Ave, California 94110, USA
    Am J Hematol 80:174-80. 2005
    ..Among systolic HF patients, the presence of a low hemoglobin concentration is not a factor in the interpretation of BNP results...
  46. ncbi Stability of B-type natriuretic peptide levels during exercise in patients with congestive heart failure: implications for outpatient monitoring with B-type natriuretic peptide
    Matthew McNairy
    Division of Cardiology and the Department of Medicine, Veteran's Affairs Medical Center and University of California, San Diego, Calif 92161, USA
    Am Heart J 143:406-11. 2002
    ..Prior activity should not influence BNP levels in patients with congestive heart failure. Therefore, when a patient presents to clinic with a marked change in their BNP level, it may reflect a real change in their condition...
  47. ncbi Association of ST2 levels with cardiac structure and function and mortality in outpatients
    Lori B Daniels
    Division of Cardiology, Department of Medicine, University of California at San Diego, San Diego, CA, USA
    Am Heart J 160:721-8. 2010
    ..The predictive value of ST2 levels in outpatients is unknown. We studied the clinical and echocardiographic correlates of ST2 levels and evaluated their prognostic use in outpatients referred for echocardiograms...
  48. ncbi Highlights of the Year in JACC 2006
    Anthony N Demaria
    Cardiology Division, University of California-San Diego, 92103-9000, USA
    J Am Coll Cardiol 49:509-27. 2007
  49. ncbi B-type natriuretic peptide levels: a potential novel "white count" for congestive heart failure
    A Maisel
    Division of Cardiology and Department of Medicine, San Diego VA Healthcare System, San Diego, California, USA
    J Card Fail 7:183-93. 2001
    ..Finally, the role of BNP in the outpatient cardiac or primary care clinic may be one of critical importance in titration of therapies as well as in assessing the state of neurohormonal compensation of the patient...
  50. ncbi Effect of nesiritide in combination with standard therapy on serum concentrations of natriuretic peptides in patients admitted for decompensated congestive heart failure
    Robert L Fitzgerald
    Veterans Affair Medical Center, San Diego, California, USA
    Am Heart J 150:471-7. 2005
    ..05) lower than baseline. CONCLUSION: Nesiritide, in combination with standard therapy, significantly lowered the endogenous concentrations of natriuretic peptides during infusion and after dosing was completed...
  51. ncbi Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function and diastolic heart failure
    Niraj Parekh
    Department of Cardiology, Veterans Affairs Hospital, University of California at San Diego, San Diego, CA, USA
    Curr Opin Cardiol 24:155-60. 2009
    ..Here we review current publications exploring the relationship between B-natriuretic peptide (BNP) and diastolic dysfunction...
  52. ncbi Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function: comparison with tissue Doppler imaging recordings
    Gary S Mak
    Cardiology Division, Department of Medicine, University of California, San Diego, Calif, USA
    Am Heart J 148:895-902. 2004
    ....
  53. ncbi B-type natriuretic peptide and impedance cardiography at the time of routine echocardiography predict subsequent heart failure events
    Luis R Castellanos
    Division of Cardiology, Department of Medicine Veteran s Affairs San Diego Healthcare System, La Jolla, CA 92161, USA
    J Card Fail 15:41-7. 2009
    ....
  54. ncbi Prognostic role of B-type natriuretic peptide levels in patients with type 2 diabetes mellitus
    Meenakshi A Bhalla
    Division of Cardiology, Veteran's Affairs Medical Center, San Diego, California 92161, USA
    J Am Coll Cardiol 44:1047-52. 2004
    ..There was a marked decrease in survival in the patient group with BNP >120 pg/ml. CONCLUSIONS: B-type natriuretic peptide appears to be a reliable predictor of future cardiac and all-cause mortality in diabetic patients...
  55. ncbi Use of biomarkers in evaluation of patients with heart failure
    Leo Slavin
    Division of Cardiology, University of California, San Diego, Calif, USA
    Contrib Nephrol 164:88-117. 2010
    ..This review focuses on biomarkers resulting from hemodynamic stress, injury and inflammation, and their clinical relevance in modern practice...
  56. ncbi B-type natriuretic peptides: a diagnostic breakthrough for clinicians
    Peter A McCullough
    Divisions of Cardiology, Nutrition, and Preventive Medicine, William Beaumont Hospital, Royal Oak, Michigan, USA
    Rev Cardiovasc Med 4:72-80. 2003
    ..This article reviews the literature concerning the use of these peptides in a variety of clinical scenarios...
  57. ncbi Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type natriuretic peptide in the emergency department
    Peter A McCullough
    William Beaumont Hospital, Royal Oak, MI 48073, USA
    Acad Emerg Med 10:198-204. 2003
    ..Heart failure, asthma, and chronic obstructive pulmonary disease (COPD) are syndromes where dyspnea and wheezing are overlapping signs, and hence, these syndromes are often difficult to differentiate...
  58. ncbi B-type natriuretic peptide in the emergency department: a valuable diagnostic aid
    Alan S Maisel
    Acad Emerg Med 12:572-3; author reply 573-4. 2005
  59. ncbi Evidence for functional heterogeneity of circulating B-type natriuretic peptide
    Faquan Liang
    Scios, Inc, Fremont, California 94555, USA
    J Am Coll Cardiol 49:1071-8. 2007
    ..These studies describe molecular forms of circulating B-type natriuretic peptide (BNP) as well as their biological activity...
  60. ncbi Relationship between obesity and B-type natriuretic peptide levels
    James McCord
    Henry Ford Heart and Vascular Institute, Henry Ford Health System, Detroit, Mich, USA
    Arch Intern Med 164:2247-52. 2004
    ..When considering demographics, severity of disease, and renal function, BMI is not independently related to BNP levels in a small subgroup when detailed information about CHF severity is known...
  61. ncbi Evolution of B-type natriuretic peptide in evaluation of intensive care unit shock
    Vikas Bhalla
    Crit Care Med 32:1787-9. 2004
  62. ncbi Gray zone BNP levels in heart failure patients in the emergency department: results from the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT) multicenter study
    Cynthia K Brenden
    Hennepin County Medical Center, Minneapolis, MN, USA
    Am Heart J 151:1006-11. 2006
    ..CONCLUSIONS: In patients with established CHF, those with gray zone BNP levels have a better prognosis than those with non-gray zone levels despite being perceived by physicians as having New York Heart Association class III or IV CHF...
  63. ncbi B-type natriuretic peptide-guided therapy and prognosis in acutely ill patients with pulmonary disease
    Alan S Maisel
    Crit Care Med 35:301-3. 2007
  64. ncbi B-type natriuretic peptide and echocardiographic determination of ejection fraction in the diagnosis of congestive heart failure in patients with acute dyspnea
    Philippe Gabriel Steg
    Cardiology, Hopital Bichat Claude Bernard, Assistance Publique Hopitaux de Paris, 46 rue Henri Huchard, 75877 Paris Cedex 18, France
    Chest 128:21-9. 2005
    ..Echocardiography and B-type natriuretic peptide (BNP) are diagnostic tests for congestive heart failure (CHF), but an emergency diagnosis can be difficult...
  65. ncbi Diagnostic value of B-Type natriuretic peptide and chest radiographic findings in patients with acute dyspnea
    Cathrine W Knudsen
    , Oslo, Norway
    Am J Med 116:363-8. 2004
    ..CONCLUSION: In patients presenting to the emergency department with acute dyspnea, BNP levels and chest radiographs provide complementary diagnostic information that may be useful in the early evaluation of heart failure...
  66. ncbi Use of natriuretic peptides in pre-participation screening of college athletes
    Lori B Daniels
    Int J Cardiol 124:411-4. 2008
    ....
  67. ncbi Reduced readmission rate for alternating diagnoses of heart failure and pulmonary disease after implementation of B-type natriuretic peptide testing
    Alan H B Wu
    Department of Pathology and Laboratory Medicine, Hartford Hospital, 80 Seymour St, Hartford, CT 06102, USA
    Eur J Heart Fail 6:309-12. 2004
    ..Effective disease management requires an accurate diagnosis. B-type natriuretic peptide (BNP) is increased in patients with HF and is normal in PD patients without cardiac involvement...
  68. ncbi A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach
    Peter S Pang
    Department of Emergency Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
    Eur Heart J 29:816-24. 2008
    ..This proposed tool requires detailed validation but has face validity for the uniform assessment of dyspnoea...
  69. ncbi Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study
    James L Januzzi
    Department of Medicine and Laboratory Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    J Am Coll Cardiol 50:607-13. 2007
    ..The aim of this study was to examine the value of measurement of the interleukin-1 receptor family member ST2 in patients with dyspnea...
  70. ncbi Algorithms for assessing cardiovascular risk in women
    Lori B Daniels
    JAMA 298:177; author reply 177-8. 2007
  71. ncbi The effect of diabetes on B-type natriuretic peptide concentrations in patients with acute dyspnea: an analysis from the Breathing Not Properly Multinational Study
    Alan H B Wu
    Department of Pathology and Laboratory Medicine, Hartford Hospital, Connecticut, USA
    Diabetes Care 27:2398-404. 2004
    ..We determined the effect of diabetes on B-type natriuretic peptide (BNP) concentrations in patients presenting to the emergency department with dyspnea...
  72. ncbi Screening for asymptomatic left ventricular dysfunction using B-type natriuretic Peptide
    Theresa A McDonagh
    Royal Brompton Hospital, London, UK
    Congest Heart Fail 14:5-8. 2008
    ....
  73. ncbi Routine measurement of natriuretic peptide to guide the diagnosis and management of chronic heart failure
    James L Januzzi
    Circulation 109:e325-6; author reply e325-6. 2004
  74. ncbi B-type natriuretic peptide. A biomarker for all the right reasons
    Vikas Bhalla
    Ital Heart J 5:417-20. 2004
  75. ncbi Evolving use of B-type natriuretic peptide in clinical practice
    Alex Harrison
    Clin Chem 50:1714-5. 2004